Geoffrey Greene to Humans
This is a "connection" page, showing publications Geoffrey Greene has written about Humans.
Connection Strength
0.581
-
PARP-1 as a novel target in endocrine-resistant breast cancer. J Exp Clin Cancer Res. 2025 Jun 16; 44(1):175.
Score: 0.030
-
Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer. Breast Cancer Res. 2024 06 07; 26(1):95.
Score: 0.028
-
Next-Generation ERa Inhibitors for Endocrine-Resistant ER+ Breast Cancer. Endocrinology. 2019 04 01; 160(4):759-769.
Score: 0.020
-
Capture of associated targets on chromatin links long-distance chromatin looping to transcriptional coordination. Nat Commun. 2016 09 16; 7:12893.
Score: 0.016
-
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. Sci Adv. 2016 06; 2(6):e1501924.
Score: 0.016
-
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation. Elife. 2016 Feb 02; 5.
Score: 0.016
-
In memoriam: Elwood Jensen (1920-2012). Endocr Rev. 2013 Dec; 34(6):761-3.
Score: 0.014
-
In memoriam: Elwood Jensen (1920-2012). Endocrinology. 2013 Oct; 154(10):3489-91.
Score: 0.013
-
Mapping ERß genomic binding sites reveals unique genomic features and identifies EBF1 as an ERß interactor. PLoS One. 2013; 8(8):e71355.
Score: 0.013
-
Removal of lactate dehydrogenase-elevating virus from human-in-mouse breast tumor xenografts by cell-sorting. J Virol Methods. 2011 May; 173(2):266-70.
Score: 0.011
-
Green tea catechins inhibit angiogenesis through suppression of STAT3 activation. Breast Cancer Res Treat. 2009 Oct; 117(3):505-15.
Score: 0.009
-
NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat Chem Biol. 2008 Apr; 4(4):241-7.
Score: 0.009
-
An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo. Endocrinology. 2008 Jun; 149(6):2970-9.
Score: 0.009
-
Molecular characterization of a B-ring unsaturated estrogen: implications for conjugated equine estrogen components of premarin. Steroids. 2008 Jan; 73(1):59-68.
Score: 0.009
-
Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea. Breast Cancer Res Treat. 2008 Feb; 107(3):359-69.
Score: 0.009
-
Structural plasticity in the oestrogen receptor ligand-binding domain. EMBO Rep. 2007 Jun; 8(6):563-8.
Score: 0.009
-
Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity. J Biol Chem. 2006 Jun 30; 281(26):17909-19.
Score: 0.008
-
Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha. Mol Endocrinol. 2005 Dec; 19(12):2930-42.
Score: 0.008
-
Structural basis for an unexpected mode of SERM-mediated ER antagonism. Mol Cell. 2005 May 13; 18(4):413-24.
Score: 0.007
-
Ligand control of coregulator recruitment to nuclear receptors. Annu Rev Physiol. 2005; 67:309-33.
Score: 0.007
-
Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors. Mol Cell. 2004 Feb 13; 13(3):317-27.
Score: 0.007
-
A structural explanation for ERalpha/ERbeta SERM discrimination. Ernst Schering Res Found Workshop. 2004; (46):33-45.
Score: 0.007
-
Nuclear receptor ligands and cofactor recruitment: is there a coactivator "on deck"? Mol Cell. 2003 Apr; 11(4):850-1.
Score: 0.006
-
Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer. Cancer Commun (Lond). 2023 05; 43(5):615-619.
Score: 0.006
-
In vivo imaging reveals estrogen receptor's hidden personality. Nat Med. 2003 Jan; 9(1):22-3.
Score: 0.006
-
Labeling of a mutant estrogen receptor with an Affimer in a breast cancer cell line. Biophys J. 2022 10 04; 121(19):3651-3662.
Score: 0.006
-
Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. Elife. 2022 05 16; 11.
Score: 0.006
-
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol. 2002 May; 9(5):359-64.
Score: 0.006
-
Selective pressure of endocrine therapy activates the integrated stress response through NF?B signaling in a subpopulation of ER positive breast cancer cells. Breast Cancer Res. 2022 03 09; 24(1):19.
Score: 0.006
-
A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice. Sci Transl Med. 2021 07 21; 13(603).
Score: 0.006
-
Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer. Mol Cancer Res. 2021 09; 19(9):1559-1570.
Score: 0.006
-
Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer. Breast Cancer Res. 2021 05 12; 23(1):54.
Score: 0.006
-
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell. 2021 06 10; 184(12):3163-3177.e21.
Score: 0.006
-
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer. Mol Cancer Ther. 2021 01; 20(1):11-25.
Score: 0.005
-
eB4CAST Approach Improves Science Communication With Stakeholders in a College-Based Health Program. Front Public Health. 2020; 8:158.
Score: 0.005
-
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells. Mol Pharmacol. 2020 07; 98(1):24-37.
Score: 0.005
-
The NF-?B Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast Cancers. Mol Cancer Res. 2020 07; 18(7):1018-1027.
Score: 0.005
-
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Rep. 2019 10 22; 29(4):889-903.e10.
Score: 0.005
-
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 1998 Dec 23; 95(7):927-37.
Score: 0.005
-
The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells. Elife. 2018 11 29; 7.
Score: 0.005
-
Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain. ACS Chem Biol. 2018 12 21; 13(12):3374-3384.
Score: 0.005
-
Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activity. Nat Commun. 2018 06 18; 9(1):2368.
Score: 0.005
-
Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. Nat Rev Cancer. 2018 06; 18(6):377-388.
Score: 0.005
-
Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Mol Pharmacol. 2018 08; 94(2):812-822.
Score: 0.005
-
Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer. Clin Cancer Res. 2018 07 15; 24(14):3433-3446.
Score: 0.005
-
Metabolism of megestrol acetate in vitro and the role of oxidative metabolites. Xenobiotica. 2018 Oct; 48(10):973-983.
Score: 0.004
-
Estrogen receptor (alpha and beta) expression in the excurrent ducts of the adult male rat reproductive tract. J Androl. 1997 Nov-Dec; 18(6):602-11.
Score: 0.004
-
Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer. Mol Cancer Res. 2017 10; 15(10):1331-1340.
Score: 0.004
-
Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists. Cancer Discov. 2017 03; 7(3):277-287.
Score: 0.004
-
Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival. Gynecol Oncol. 1996 Oct; 63(1):28-33.
Score: 0.004
-
A constructivist perspective on clinical social work practice with ethnically diverse clients. Soc Work. 1996 Mar; 41(2):172-80.
Score: 0.004
-
Estrogen receptor accessory proteins: effects on receptor-DNA interactions. Environ Health Perspect. 1995 Oct; 103 Suppl 7:23-8.
Score: 0.004
-
Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli. Mol Endocrinol. 1995 Jun; 9(6):647-58.
Score: 0.004
-
14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget. 2015 Feb 28; 6(6):3540-52.
Score: 0.004
-
Immunocytochemical assay for androgen receptors in prostate cancer: a prospective study of 63 cases with long-term follow-up. Ann Surg Oncol. 1994 Nov; 1(6):495-503.
Score: 0.004
-
The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol Endocrinol. 1994 Oct; 8(10):1407-19.
Score: 0.004
-
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor a modulation, uncoupling nuclear and membrane activation. EMBO Mol Med. 2014 Oct; 6(10):1328-46.
Score: 0.004
-
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013 Dec; 45(12):1439-45.
Score: 0.003
-
Immunocytochemical assay for estrogen receptor with monoclonal antibody D753P gamma in routinely processed formaldehyde-fixed breast tissue. Comparison with frozen section assay and with monoclonal antibody H222. Cancer. 1993 Jun 01; 71(11):3541-6.
Score: 0.003
-
Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics. PLoS One. 2013; 8(5):e64091.
Score: 0.003
-
Overcoming mutation-based resistance to antiandrogens with rational drug design. Elife. 2013 Apr 09; 2:e00499.
Score: 0.003
-
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun. 2013; 4:1393.
Score: 0.003
-
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion. Breast Cancer Res Treat. 2013 Jan; 137(2):373-82.
Score: 0.003
-
Estrogen and progesterone receptor structure and action in breast cancer cells. Cancer Treat Res. 1992; 61:301-15.
Score: 0.003
-
Immunohistochemical localization of progesterone receptor in human decidua of early pregnancy. Hum Reprod. 1992 Jan; 7(1):123-7.
Score: 0.003
-
An immunohistochemical evaluation of progesterone receptor in frozen sections, paraffin sections, and cytologic imprints of breast carcinomas. Cancer. 1991 Jan 15; 67(2):455-62.
Score: 0.003
-
RAC3 is a pro-migratory co-activator of ERa. Oncogene. 2011 Apr 28; 30(17):1984-94.
Score: 0.003
-
Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer. 1990 Oct 15; 66(8):1663-70.
Score: 0.003
-
Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand. Am J Pathol. 1989 Nov; 135(5):857-64.
Score: 0.003
-
Immunohistochemical assessment of estrogen and progesterone receptors in stored imprints and cryostat sections of breast carcinomas. Ann Surg. 1989 Aug; 210(2):224-8.
Score: 0.003
-
Characterization of the ovarian and reproductive abnormalities in prepubertal and adult estrogen non-responsive estrogen receptor alpha knock-in (ENERKI) mice. Steroids. 2009 Nov; 74(12):913-9.
Score: 0.003
-
Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort. BMC Cancer. 2009 Jan 30; 9:43.
Score: 0.002
-
Purification of T47D human progesterone receptor and immunochemical characterization with monoclonal antibodies. Mol Endocrinol. 1988 Aug; 2(8):714-26.
Score: 0.002
-
Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor. Am J Pathol. 1988 Apr; 131(1):112-24.
Score: 0.002
-
Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. Endocrinology. 1988 Mar; 122(3):1165-75.
Score: 0.002
-
Estrogen and progesterone receptor measurements with monoclonal antibodies. Int J Biol Markers. 1988 Jan-Mar; 3(1):57-9.
Score: 0.002
-
CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor. Mol Endocrinol. 2008 Feb; 22(2):263-72.
Score: 0.002
-
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands. Chem Biol. 2007 Jun; 14(6):659-69.
Score: 0.002
-
Structural analysis of covalently labeled estrogen receptors by limited proteolysis and monoclonal antibody reactivity. Biochemistry. 1987 Apr 21; 26(8):2364-73.
Score: 0.002
-
Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains. J Med Chem. 2007 Jan 25; 50(2):399-403.
Score: 0.002
-
Immunochemical studies of estrogen receptors. Prog Clin Biol Res. 1987; 249:283-305.
Score: 0.002
-
Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects. Health Qual Life Outcomes. 2006 Jul 17; 4:43.
Score: 0.002
-
Estrogen receptor localization in the female genital tract. Am J Pathol. 1986 May; 123(2):280-92.
Score: 0.002
-
Sequence and expression of human estrogen receptor complementary DNA. Science. 1986 Mar 07; 231(4742):1150-4.
Score: 0.002
-
Structure and dynamics of the estrogen receptor. J Steroid Biochem. 1986 Jan; 24(1):1-7.
Score: 0.002
-
Conformation-specific affinity purification of proteins using engineered binding proteins: application to the estrogen receptor. Protein Expr Purif. 2006 Jun; 47(2):348-54.
Score: 0.002
-
Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas. J Clin Endocrinol Metab. 1985 Sep; 61(3):412-7.
Score: 0.002
-
Immunoelectron microscopic localization of estrogen receptor with monoclonal estrophilin antibodies. J Histochem Cytochem. 1985 Sep; 33(9):915-24.
Score: 0.002
-
Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays. Lab Invest. 1985 Sep; 53(3):349-61.
Score: 0.002
-
The use of monoclonal antibodies to estrogen receptors (ER) for immunoperoxidase detection of ER in paraffin sections of human breast cancer tissue. J Histochem Cytochem. 1985 Feb; 33(2):87-92.
Score: 0.002
-
Maxillary sinus cancer: a study of 33 cases. J Oral Pathol. 1985 Jan; 14(1):27-36.
Score: 0.002
-
Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res. 1985 Jan; 45(1):293-304.
Score: 0.002
-
Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle. Lab Invest. 1984 Nov; 51(5):495-503.
Score: 0.002
-
Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol. 2004 Dec; 18(12):2854-65.
Score: 0.002
-
An immunocytochemical method for demonstrating estrogen receptor in human uterus using monoclonal antibodies to human estrophilin. Lab Invest. 1984 Apr; 50(4):480-6.
Score: 0.002
-
Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature. 1984 Feb 23-29; 307(5953):745-7.
Score: 0.002
-
Immunochemical studies of estrogen receptors. J Steroid Biochem. 1984 Jan; 20(1):51-6.
Score: 0.002
-
Consensus statement: Expedition Inspiration fund for breast cancer research meeting 2002. Breast Cancer Res Treat. 2003 Mar; 78(1):127-31.
Score: 0.002
-
Monoclonal antibodies as probes for estrogen receptor detection and characterization. J Steroid Biochem. 1982 Mar; 16(3):353-9.
Score: 0.001
-
A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity. Mol Cell Biol. 2001 Mar; 21(6):2235-47.
Score: 0.001
-
Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol. 2000 Nov 30; 74(5):311-7.
Score: 0.001
-
Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci U S A. 1980 Sep; 77(9):5115-9.
Score: 0.001
-
Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators. Mol Endocrinol. 1999 Jun; 13(6):897-909.
Score: 0.001
-
Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol. 1998 Apr; 18(4):1927-34.
Score: 0.001
-
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 1997 Oct 16; 389(6652):753-8.
Score: 0.001
-
Isolation and cloning of human peroxisome proliferator activated receptor gamma cDNA. Adv Exp Med Biol. 1997; 400A:253-60.
Score: 0.001
-
Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 1996 Sep 15; 94(6):1402-7.
Score: 0.001
-
Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Mol Endocrinol. 1996 Jun; 10(6):694-704.
Score: 0.001
-
Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis. Biochemistry. 1995 Oct 03; 34(39):12605-15.
Score: 0.001
-
Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay. Anticancer Res. 1995 Mar-Apr; 15(2):649-54.
Score: 0.001
-
Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr. 1995; 4(4-5):281-99.
Score: 0.001
-
Human estrogen receptor bound to an estrogen response element bends DNA. Mol Endocrinol. 1993 Mar; 7(3):331-40.
Score: 0.001
-
The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Breast Cancer Res Treat. 1993; 26(2):191-202.
Score: 0.001
-
The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol. 1992 Feb; 6(2):157-67.
Score: 0.001
-
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res. 1992 Jan 15; 52(2):483-6.
Score: 0.001
-
Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays. Eur J Cancer. 1992; 28(2-3):322-6.
Score: 0.001
-
Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors. J Natl Cancer Inst. 1991 Aug 21; 83(16):1157-60.
Score: 0.001
-
Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis. Cancer Res. 1991 Jan 01; 51(1):239-44.
Score: 0.001
-
Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases. Zentralbl Pathol. 1991; 137(3):227-32.
Score: 0.001
-
Estrogen receptor gene methylation in human breast tumors. Cancer Res. 1990 Jul 01; 50(13):3974-8.
Score: 0.001
-
The use of fine needle aspirates in the evaluation of progesterone receptor content in breast cancer. Acta Cytol. 1990 Jan-Feb; 34(1):27-30.
Score: 0.001
-
Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor. J Biol Chem. 1989 Oct 15; 264(29):17476-85.
Score: 0.001
-
Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors. Cancer Res. 1989 Sep 15; 49(18):5176-9.
Score: 0.001
-
Immunocytochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation. Mod Pathol. 1989 Sep; 2(5):449-55.
Score: 0.001
-
Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res. 1989 Feb 15; 49(4):1052-6.
Score: 0.001
-
Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol Endocrinol. 1989 Feb; 3(2):295-304.
Score: 0.001
-
Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res. 1989 Jan 01; 49(1):145-8.
Score: 0.001
-
Progesterone receptors in the human heart and great vessels. Lab Invest. 1988 Sep; 59(3):353-6.
Score: 0.001
-
Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab. 1988 Aug; 67(2):334-40.
Score: 0.001
-
Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 1988 Jul 01; 241(4861):81-4.
Score: 0.001
-
Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology. 1988 Mar; 122(3):935-44.
Score: 0.001
-
Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol. 1988 Mar; 2(3):263-71.
Score: 0.001
-
Immunostaining of estrogen receptor in paraffin sections of breast carcinomas using monoclonal antibody D75P3 gamma: effects of fixation. Am J Surg Pathol. 1987 Dec; 11(12):943-50.
Score: 0.001
-
Cellular progesterone receptor phosphorylation in response to ligands activating protein kinases. Biochem Biophys Res Commun. 1987 Aug 14; 146(3):1357-65.
Score: 0.001
-
The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2. Proc Natl Acad Sci U S A. 1987 May; 84(9):2877-81.
Score: 0.001
-
Structural organization and regulation of the chicken estrogen receptor. Mol Endocrinol. 1987 Jan; 1(1):25-35.
Score: 0.001
-
Estrogen receptor localization in formalin-fixed, paraffin-embedded endometrium and endometriotic tissues. Int J Gynecol Pathol. 1987; 6(2):140-51.
Score: 0.001
-
Molecular cloning of the chicken progesterone receptor. Science. 1986 Aug 15; 233(4765):767-70.
Score: 0.001
-
Cloning of the human oestrogen receptor cDNA. J Steroid Biochem. 1986 Jan; 24(1):77-83.
Score: 0.000
-
Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci U S A. 1985 Dec; 82(23):7889-93.
Score: 0.000
-
Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018. Endocrinology. 1985 Oct; 117(4):1409-17.
Score: 0.000
-
Characterization of the subunit nature of nuclear estrogen receptors by chemical cross-linking and dense amino acid labeling. Endocrinology. 1985 Aug; 117(2):515-22.
Score: 0.000
-
Relation of estrogen receptor expression to clonal growth and antiestrogen effects on human breast cancer cells. Cancer Res. 1985 Jun; 45(6):2720-4.
Score: 0.000
-
A novel nuclear form of estradiol receptor in MCF-7 human breast cancer cells. Science. 1984 Sep 14; 225(4667):1162-5.
Score: 0.000
-
Monoclonal and anti-idiotypic antibodies as probes for receptor structure and function. Fed Proc. 1984 Jul; 43(10):2532-9.
Score: 0.000
-
Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor. Cancer Res. 1984 Mar; 44(3):1012-8.
Score: 0.000
-
Estrogen receptors, antibodies and hormone dependent cancer. Prog Clin Biol Res. 1984; 142:1-21.
Score: 0.000
-
Estrogen receptor transformation in MCF-7 breast cancer cells: characterization by immunochemical and sedimentation analyses. Endocrinology. 1984 Jan; 114(1):296-8.
Score: 0.000
-
Estrogen receptors in human prostate: evidence for multiple binding sites. J Clin Endocrinol Metab. 1983 Jul; 57(1):166-76.
Score: 0.000
-
Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody. Breast Cancer Res Treat. 1983; 3(3):267-77.
Score: 0.000
-
Receptors reconsidered: a 20-year perspective. Recent Prog Horm Res. 1982; 38:1-40.
Score: 0.000
-
Squamous-cell carcinoma of the floor of the mouth. Oral Surg Oral Med Oral Pathol. 1978 Apr; 45(4):568-79.
Score: 0.000